Young v. Key Pharmaceuticals, Inc.
Is it still good law? What later courts have actually done to this case.
Status
More on how this was screened
Many later opinions cite Young's summary judgment rule and append an “overruled on other grounds” notation pointing to the Washington Supreme Court's 1996 decision in the same litigation, 130 Wn.2d 160. That decision was read directly. It affirms the prior dismissal of the medical defendants and does not say it overrules the 1989 decision. The notation alone does not support an adverse entry.
56 later cases cite Young v. Key Pharmaceuticals, Inc.; 56 of those citations sat close to treatment language and were flagged for reading, and all of them have been read. Citations that did not sit near treatment language were not flagged and were not read one by one, so a court that weakened this case without using any of that language would not appear here.
Relying on Young v. Key Pharmaceuticals, Inc.?
This page shows what later courts did to it. Ask about your specific facts and see whether it still carries your argument, with citations you can check.
No reviewed court has overruled or limited this case.
Every one of the 56 flagged citations was read, and each turned out to be something other than adverse treatment: a routine application, a party's argument the court rejected, or the case itself discussing older law. That reading is the finding this page exists to report.
Does this case still carry your argument?
Describe your facts. Ezel reads Young v. Key Pharmaceuticals, Inc. and the cases that treated it, then tells you whether it still holds for your situation, with citations.
Opens in Ezel Pro.
- Checks the law as it stands today, not only this page
- Cites every source it relies on, so you can verify it
- Chat, drafting and research in one workspace